Evaluation of the impact of effective compounds of Teucrium Chamaedrys on visual function indices in patients with COVID-19.
Phase 2
- Conditions
- U07.1COVID-19.COVID-19, virus identified
- Registration Number
- IRCT20211223053497N1
- Lead Sponsor
- Artesh University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 132
Inclusion Criteria
The age of the participants is between 25 to 40 years old
Positive results of Real-time PCR tests (positive nasopharyngeal and oropharyngeal swab samples)
With symptoms of decreased visual acuity, fluctuating or wavy vision, and or inflammation of the ocular conjunctiva when visiting the hospital
Exclusion Criteria
History of underlying systemic diseases such as diabetes
History of eye diseases, especially retinal lesions
Best corrected visual acuity less than 20/30
History of cataract surgery
History of various types of manifest deviations (strabismus) and amblyopia
Use of drugs affecting the structure and function of the retina and visual system such as hydroxychloroquine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method